CE Marking: Obtaining and Maintaining EU Compliance Under the New Medical Device Directive

Quantity Discounts
1 - 9999
1 - 9999
1 - 9999
Click here to listen to an interview with Eric Henning.

While nearly all medical devices sold in the European Union (EU), the world's second largest medical device market, must carry a CE Marking, obtaining the marking can be complicated. To make matters worse, the European Parliament has recently adopted 141 amendments to its medical device directives (MDD), including software in devices, device construction and safety labeling.

Failure to understand this difficult process and the impact of the new amendments can lead to delays in approval, repeat paperwork, additional costs — or worse — outright denial of market access.

Often it is necessary to hire an authorized representative to make your case before the European Commission and a notified body must be contracted to run device testing, along with the submission of various documents — all of which may be unfamiliar to anyone outside the EU.

How can you make sense of all this and still get that CE Marking for your medical device?

Find out in this 90-minute Encore presentation. Regulatory requirements expert Eric Henning will offer front-line, real-world advice on how to effectively and efficiently obtain and maintain a CE Marking. He will explain the four device categories and share what the MDD amendments mean for medical device companies entering the EU, as well as those already established.

Sign up your entire team to listen in and discover:

  • What makes your device a Class I, IIa, IIb or III, and what that means to you in terms of compliance burden
  • Specific elements notified bodies look for in companies when assessing compliance to 93/42/EEC (MDD)
  • Steps to organize a technical file that will help avoid delays or denial of CE Marking approval
  • What is expected for clinical data
  • The important changes in the MDD including the practical impact they will have, and when companies will likely have to comply
  • Strategies to show compliance to the essential requirements (Annex I)
  • Routes to conformity with the essential requirements
  • Ways to ensure audits go smoothly
  • Tactics for maintaining the CE Marking

Register now to avoid having your medical device delayed or denied approval for sale in the EU. Plus, you'll get an opportunity to ask your toughest questions during the Q&A session.

This presentation is a must for professionals in device, diagnostics and consulting companies including:
  • Auditors
  • Compliance officers
  • Consultants/service providers
  • Data management and statistics personnel
  • Engineering and design control teams
  • Executive management
  • General/corporate counsel
  • Managers
  • Manufacturing directors and supervisors
  • Personnel new to the industry
  • QA/QC personnel
  • R&D staff
  • Regulatory/legislative affairs professionals
  • Risk management specialists
  • Strategic planning and business development staff

Eric Henning, senior project manager at the Notified Body KEMA, currently focuses on regulatory requirements for active implantable medical devices. He previously worked as worldwide compliance manager for a division of ABB, producing industrial and medical equipment. Eric has also worked as project leader for a nationally recognized  testing lab and has assessed design and production control systems.

Register now!

Date: Nov. 19 – Dec. 7, 2007
Location: Your office or conference room (no need to travel!)
Time: Anytime

Gather your team for maximum benefit! Your investment is for one dial-in.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or 1 (703) 538-7600 globally
to learn about our special multisite discount.

We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.

Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600

Registrations may not be cancelled. Please contact customer service to make any substitutions.